Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia. [electronic resource]
Producer: 20180625Description: 656-661 p. digitalISSN:- 1097-6809
- Academic Medical Centers
- Clinical Protocols
- Critical Illness
- Double-Blind Method
- Exercise Tolerance
- Humans
- Injections, Intramuscular
- Ischemia -- diagnosis
- Lower Extremity -- blood supply
- Mesenchymal Stem Cell Transplantation -- adverse effects
- Neovascularization, Physiologic
- Netherlands
- Peripheral Arterial Disease -- diagnosis
- Recovery of Function
- Research Design
- Time Factors
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.